Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("MAZINDOL")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 223

  • Page / 9

Export

Selection :

  • and

Systemic mazindol reduces food intake in rats via suppression of meal size and meal numberWELLMAR, P. J.Journal of psychopharmacology (Oxford). 2008, Vol 22, Num 5, pp 532-535, issn 0269-8811, 4 p.Article

Amphetamines to counteract opioid-induced sedationCOREY, P; HECK, A. M; WEATHERMON, R. A et al.The Annals of pharmacotherapy. 1999, Vol 33, Num 12, pp 1362-1366, issn 1060-0280Article

Studies on the adsorptive behaviour of mazindol and its adsorptive stripping voltammetryMIAO, H; HU, J; LU, Y et al.Analytica chimica acta. 1998, Vol 358, Num 3, pp 297-303, issn 0003-2670Article

STRUCTURE DETERMINATION OF THE ANOREXIC AGENT MAZINDOL = DETERMINATION DE LA STRUCTURE DE L'AGENT ANOREXIGENE MAZINDOLBARCZA S; HOULIHAN WJ.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 5; PP. 829-831; BIBL. 4 REF.Article

The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigmRYGULA, Rafal; SZCZECH, Ewa; PAPCIAK, Justyna et al.Behavioural brain research. 2014, Vol 270, pp 206-212, issn 0166-4328, 7 p.Article

Validated method for determination of mazindol in human plasma by liquid chromatography/tandem mass spectrometryKIM, Sung-Su; LEE, Heon-Woo; LEE, Kyung-Tae et al.Journal of chromatography. B. 2009, Vol 877, Num 10, pp 1011-1016, issn 1570-0232, 6 p.Article

Synergistic interaction between mazindol, an anorectic drug, and swim-stress on analgesic responses in the formalin test in miceVENDRUSCOLO, Leandro Franco; NAOTO TAKAHASHI, Reinaldo.Neuroscience letters. 2004, Vol 355, Num 1-2, pp 13-16, issn 0304-3940, 4 p.Article

UNEXPECTED DIFFERENCES BETWEEN MAZINDOL AND ITS HOMOLOGS ON BIOCHEMICAL AND BEHAVIORAL RESPONSESHEIKKILA RE; CABBAT FS; MANZINO L et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 217; NO 3; PP. 745-749; BIBL. 20 REF.Article

TRATAMIENTO DE LA OBESIDAD CON MAZINDOL (AN-448). RESULTADOS DE ENSAYO ABIERTO Y DOBLE CIEGO = TRAITEMENT DE L'OBESITE AVEC LE MAZINDOL (AN-448). RESULTATS D'UN ESSAI OUVERT ET A DOUBLE INSUHAWKINS CARRANZA FG; FLOREZ TASCON M; SCHULLER A et al.1976; MED. CLIN.; ESP.; DA. 1976; VOL. 66; NO 9; PP. 460-463; ABS. ANGL.; BIBL. 13 REF.Article

ESSAI CONTROLE D'UN ANOREXIGENE (AN 448) DANS LE TRAITEMENT DE L'OBESITE DE L'ENFANTCANLORBE P; BORNICHE P; TOUBLANC JE et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 16; PP. 1061-1062; BIBL. 10 REF.Article

High-performance liquid chromatographic method for the disposition of mazindol and its metabolite 2-(2-aminoethyl)-3-(p-chlorophenyl)-3-hydroxyphthalimidine in mouse brain and plasmaNAKASHIMA, Kenichiro; KADDOUMI, Amal; MORI, Miwako et al.Analytica chimica acta. 2004, Vol 502, Num 1, pp 39-47, issn 0003-2670, 9 p.Article

A COMPARISON OF MAZINDOL (TERONAC) WITH DIETHYLPROPION IN THE TREATMENT OF EXOGENOUS OBESITYMURPHY JE; MOLLA AL; CROWDER D et al.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 3; PP. 202-206; BIBL. 13REF.Serial Issue

A reliable model of intravenous MDMA self-administration in naive miceTRIGO, José Manuel; PANAYI, Fany; SORIA, Guadalupe et al.Psychopharmacologia. 2006, Vol 184, Num 2, pp 212-220, issn 0033-3158, 9 p.Article

DOUBLE-BLIND TRIAL OF MAZINDOL IN OVERWEIGHT PATIENTS. = ESSAI EN DOUBLE AVEUGLE DU MAZINDOL CHEZ DES MALADES AYANT UN POIDS TROP ELEVEHEBER KR.1975; MED. J. AUSTRAL.; AUSTRAL.; DA. 1975; VOL. 2; NO 14; PP. 566-567; BIBL. 1 REF.Article

Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated ratsKAWAKAMI, Yasuhiro; KITAMURA, Yoshihisa; ARAKI, Hiroaki et al.Pharmacology, biochemistry and behavior. 2005, Vol 81, Num 1, pp 65-70, issn 0091-3057, 6 p.Article

Amphetamine, mazindol, and fencamfamine in narcolepsySHINDLER, J; SCHACHTER, M; BRINCAT, S et al.British medical journal (1857). 1985, Vol 290, Num 6476, pp 1167-1170, issn 0007-1447Article

Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashionWU, Q; COFFEY, L. L; REITH, M. E. A et al.Journal of neurochemistry. 1997, Vol 69, Num 3, pp 1106-1118, issn 0022-3042Article

MAZINDOL-INDUCED LITHIUM TOXICITYHENDY MS; DOVE AF; ARBLASTER PG et al.1980; BRIT. MED. J.; GBR; DA. 1980; NO 6215; PP. 684-685; BIBL. 5 REF.Article

MEDIKAMENTOESE APPETITREGULATION. KONTROLLIERTE UNTERSUCHUNG MIT DEM APPETITHEMMER AN-448 (MAZINDOL, TERONAC). = REGULATION MEDICAMENTEUSE DE L'APPETIT. ESSAI THERAPEUTIQUE CONTROLE DE L'ANOREXIGENE AN-448 MAZINDOL TERONAC)UNDEUTSCH K; LANG E.1976; THERAPIEWOCHE; DTSCH.; DA. 1976; VOL. 26; NO 31; PP. 4922-4927 (4P.); BIBL. 11 REF.Article

THE EFFECTS OF 5-HYDROXY-5-(4PRIME -CHLOROPHENYL)-2,3-DIHYDRO-5H-IMIDAZO (2,1-A) ISOINDOLE (MAZINDOL, SAH 42 (-548) ON THE METABOLISM OF BRAIN NOREPINEPHRINEENGSTROM RG; KELLY LA; GOGERTY JH et al.1975; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1975; VOL. 214; NO 2; PP. 308-321; BIBL. 19 REF.Article

A CONTROLLED TRIAL OF MAZINDOL (SANJOREX, TERONAC) IN THE MANAGEMENT OF THE OBESE RHEUMATIC PATIENTS = UN ESSAI CONTROLE DU MAZINDOL (SANJOREX, TERONAC) DANS LE TRAITEMENT DE MALADES OBESES ATTEINTS DE RHUMATISMETHORPE PC; ISAAC PF; RODGERS J et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 17; NO 2; PP. 149-155; BIBL. 11 REF.Article

MAZINDOL SELF-ADMINISTRATION IN THE RHESUS MONKEYWILSON MC; SCHUSTER CR.1976; PHARMACOL. BIOCHEM. BEHAV.; U.S.A.; DA. 1976; VOL. 4; NO 2; PP. 207-210; BIBL. 6 REF.Article

SOLVOLYSIS OF A SUBSTITUTED IMIDAZOLINE, MAZINDOL.MAULDING HV; TURI P; GROSSMAN D et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 11; PP. 1833-1838; BIBL. 8 REF.Article

A NON-AMPHETAMINE ANORECTIC AGENT: PRECLINICAL BACKGROUND AND A DOUBLE-BLIND CLINICAL TRIAL. = UN AGENT ANOREXIGENE NON AMPHETAMINIQUE: DONNEES DE BASE PRECLINIQUES ET ESSAI CLINIQUE EN DOUBLE AVEUGLESCHWARTZ LN.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 5; PP. 328-332; BIBL. 12 REF.Article

COMPARISON OF A NEW ANORECTIC AGENT AN448 WITH FENFLURAMINE IN THE TREATMENT OF REFRACTORY OBESITY = COMPARAISON ENTRE UN NOUVEL ANOREXIGENE LE AN-448, ET LA FENFLURAMINE DANS LE TRAITEMENT DE L'OBESITE REFRACTAIREGOLDRICK RB; NESTEL PJ; HAVENSTEIN N et al.1974; MED. J. AUSTRAL.; AUSTRAL.; DA. 1974; VOL. 1; NO 22; PP. 882-885; BIBL. 18REF.Article

  • Page / 9